The nuclear receptor known as the androgen receptor (AR) is activated when either the androgenic hormones testosterone or dihydrotestosterone bind to it in the cytoplasm before moving into the nucleus. The receptor separates from supporting proteins after binding the hormone ligand, moves into the nucleus, dimerizes, and then activates transcription of androgen-responsive genes. The progesterone receptor is most similar to the androgen receptor, and progestins can block the androgen receptor when used in higher doses. The androgen receptor's primary role is that of a DNA-binding transcription factor that controls gene expression. The development and maintenance of the male sexual phenotype depend heavily on genes that are regulated by androgen. Complete androgen insensitivity (CAIS) is a condition that is also correlated with mutations in this gene.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V98841 | (+)-JJ-74-138 | 2135545-34-3 | (+)-JJ-74-138 is a novel noncompetitive androgen receptor (AR) antagonist that inhibits enzalutamide-resistant castration-resistant prostate cancer (CRPC). |
|
V89087 | (-)-Erteberel | 533884-08-1 | (-)-Erteberel is a selective estrogen receptor β (ERβ) agonist. |
|
V121145 | (–)-JJ-450 | 1998094-23-7 | (–)-JJ-450 is a non-competitive androgen receptor (AR) antagonist. |
|
V121529 | (3R,3′R)-Astaxanthin | 60760-95-4 | (3R,3′R)-Astaxanthin is an androgen receptor binding agent. |
|
V89074 | (3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol | 1393651-00-7 | (3β,4β,17β)-17-(2-Pyridinylmethyl)androst-5-ene-3,4,17-triol is an androstane derivative with anticancer activity. |
|
V89081 | (R,R)-THC | 221368-54-3 | (R,R)-THC is an ERα agonist and ERβ antagonist, with Ki values of 9.0 nM and 3.6 nM for ERα and ERβ, respectively. |
|
V122053 | (rel)-BMS-641988 | 573738-99-5 | (rel)-BMS-641988 is a relative configuration of BMS-641988. |
|
V89083 | 17-Epiestriol | 1228-72-4 | 17-Epiestriol is an estrogen metabolite and a selective estrogen receptor (ER) β agonist. |
|
V102591 | 19-Noretiocholanolone | 33036-33-8 | 19-Norepinephrine is an androgenic steroid metabolite. |
|
V123798 | 2-(2-Methoxyphenoxy)ethylamine hydrochloride | 64464-07-9 | 2-(2-Methoxyphenoxy)ethylamine hydrochloride is a mixed agonist/antagonist. |
|
V125392 | 3'-Hydroxy stanozolol | 125709-39-9 | 3'-Hydroxy stanozolol is the main metabolite of the anabolic androgenic steroid stanozolol. |
|
V125335 | 3-Cl-Pyridine-amide-acrylaldehyde-piperazine | 3-Cl-Pyridine-amide-acrylaldehyde-piperazine is a synthetic intermediate for LO-4-25. | |
|
V114726 | 3-Oxochol-5-en-24-oic acid | 847232-54-6 | 3-O-5-en-24-acid is a rare bile acid produced by gut microbiota. |
|
V125667 | 3βHSD1-IN-1 | 3082852-63-6 | 3βHSD1-IN-1 is an inhibitor of 3β-hydroxysteroid dehydrogenase 1 (3βHSD1) with an IC50 value of 55 nM. |
|
V126133 | 4-AcO-DALT hydrochloride | 4-AcO-DALT hydrochloride is a tryptamine compound with psychoactive effects. | |
|
V127278 | 6-Amino-5-bromoquinoxaline | 50358-63-9 | 6-Amino-5-bromoquinoxaline is a 2-(arylamino)imidazole derivative and a precursor for α1- and α2-androgen receptor antagonists. |
|
V107122 | 6α-Chloro testosterone | 847674-32-2 | 6α-Chlorotestosterone is a metabolizable androgenic steroid. |
|
V102630 | 6α-Hydroxy metandienone | 55720-48-4 | 6α-Hydroxyandrostenedione is the androgenic anabolic steroid metabolite of androstenedione. |
|
V8411 | AC-262536 | 870888-46-3 | AC-262536 (AC262536) is anovel selective androgen receptor modulator (SARM) with beneficial anabolic effects. |
|
V10225 | ACP-105 | 899821-23-9 | ACP-105 (ACP105; ACP 105) is a novel, nonsteroidal and orally bioactive SARM (selective androgen receptor modulator) that has been investigated for the treatment of age-related cognitive decline. |